Prelude Capital Management’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,403	Closed	-$605K	–	1269
2024 Q1	$605K	Buy	+3,403	New	+$605K	0.03%	491
2018 Q3	–	Sell	-100	Closed	-$1K	–	1522
2018 Q2	$1K	Buy	+100	New	+$1K	﹤0.01%	1315